PetMed Express(NASDAQ) PETS

Market Cap$42.10M

Since IPO (1997)+215%

5 Year-92%

1 Year-39%

1 Month+3%

$1.97

+0.00%

+0.00Today

After hours$1.97+$0.00 (+0.00%)

PetMed Express last closing stock price
Metric	Price	Date
Last close	USD 1.97	2026-08-06

PetMed Express stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-0.51%	USD 1.98	2026-07-30
1 month	+2.6%	USD 1.92	2026-07-07
3 month	-13.6%	USD 2.28	2026-05-08
Year to date	-38.44%	USD 3.20	2025-12-31
1 year	-38.82%	USD 3.22	2025-08-06
3 year	-84.89%	USD 13.04	2023-08-07
5 year	-92.28%	USD 25.51	2021-08-06
Since inception	+215.25%	USD 0.62	1997-09-16

PetMed Express Financials at a Glance

Market Cap

$42.10M

Revenue (TTM)

$179.02M

Net Income (TTM)

-$57.29M

EPS (TTM)

-$2.75

P/E Ratio

-0.72

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$1.97

Volume

38,594.936

Open

$1.97

Price

$1.97

Volume

38,594.936

Open

$1.97

Previous Close

$1.97

Daily Range

$1.96 - $1.98

52-Week Range

$1.57 - $4.10

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$1.97

Volume

38,594.936

Open

$1.97

Previous Close

$1.97

Daily Range

$1.96 - $1.98

52-Week Range

$1.57 - $4.10

Estimated Earnings Date

Aug 13, 2026

PETS News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PetMed Express

PetMed Express helps pet owners get prescription and non-prescription medicines for dogs, cats, and horses. Customers order online or by phone and receive home delivery. The company also offers pet health supplies and food for everyday pet care needs.

Products and Services

Prescription Medications: Heartworm, flea, tick, arthritis, and other specialty drugs for pets (85.1% of Q3 FY2025 sales from reorders).
Non-Prescription Products: Flea control, vitamins, supplements, treats, and hygiene items for pet wellness.
Pet Supplies: Food, beds, crates, and accessories for dogs, cats, and horses.
Membership Programs: PetPlus and partner memberships offer discounts, free shipping, and telehealth access (3.5% of Q3 FY2025 sales).
AutoShip & Save and Membership Programs: Combined, these recurring subscriptions accounted for 56.2% of Q3 FY2025 gross sales.

Growth and Expansion

Acquired PetCareRx in 2023, expanding product range and membership offerings.
Formed exclusive telehealth partnership with Vetster in 2023; invested $5.3M for 4.8% ownership.
Launched new membership models and expanded recurring revenue programs in 2024.
Implemented a Rights Agreement in December 2024 to protect against hostile takeovers.

What Makes PetMed Express Stand Out

PetMed Express uses a direct-to-consumer model, selling online and by phone to reach pet owners nationwide. Its recurring revenue programs, like AutoShip & Save, help stabilize sales. The company’s exclusive telehealth partnership adds veterinary services to its product mix.

Five Things You Need to Know

Revenue was $44M in Q2 2026, down 25.5% from Q2 2025.
Gross profit was $12M in Q2 2026, down 28.3% year-over-year.
Net loss was $8M in Q2 2026, compared to $554K profit in Q2 2025.
Cash and cash equivalents were $50.1M as of December 31, 2024.
No debt; all sales are domestic and direct to consumers.

Bottom Line

PetMed Express has shifted from a traditional pet pharmacy to a multi-channel, recurring revenue business. The company faces sales declines but continues to adapt through partnerships and expanded services.

AI Generated • Apr 16, 2026

Industry

Specialty Retail

Sector

Consumer Discretionary

Employees

189

CEO

Leslie C. G. Campbell

Website

www.1800petmeds.com

Headquarters

Delray Beach, FL 33445, US

PETS Financials

Key Financial Metrics (TTM)

Gross Margin

22.81%

Operating Margin

-17.55%

Net Income Margin

-32.00%

Return on Equity

-146.59%

Return on Capital

-106.58%

Return on Assets

-70.56%

Earnings Yield

-1.39%

Dividend Yield

0.00%

Payout Ratio

-0.04%

Stock Overview

Market Cap

$42.10M

Shares Outstanding

21.37M

Volume

38.59K

Avg. Volume

660.05K

Financials (TTM)

Gross Profit

$40.83M

Operating Income

-$31.42M

EBITDA

-$48.90M

Operating Cash Flow

-$28.39M

Capital Expenditure

-$4.62M

Free Cash Flow

-$33.01M

Cash & ST Invst.

$21.41M

Total Debt

$535.00K

PetMed Express Performance Analysis

PetMed Express annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-03-31	USD 256,579,000	-6.2%
2024	2024-03-31	USD 274,095,000	6.8%
2025	2025-03-31	USD 226,972,000	-17.2%
2026	2026-03-31	USD 179,021,000	-21.1%

PetMed Express sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2025-06-30	10.1%
Q2	2025-09-30	-13.3%
Q3	2025-12-31	-8.3%
Q4	2026-03-31	5.3%

PetMed Express annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-03-31	USD 0.25	-75.6%
2024	2024-03-31	USD -0.37	N/A
2025	2025-03-31	USD -0.30	-16.8%
2026	2026-03-31	USD -2.74	799.2%

PetMed Express sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2025-06-30	-194.6%
Q2	2025-09-30	75.2%
Q3	2025-12-31	-22.0%
Q4	2026-03-31	62.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

$42.82M

-7.9%

Gross Profit

$6.84M

-63.9%

Gross Margin

15.97%

N/A

Market Cap

$42.10M

N/A

Market Cap/Employee

$222.77K

N/A

Employees

189

N/A

Net Income

-$4.06M

+65.1%

EBITDA

-$3.27M

-18.9%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

$21.41M

-60.9%

Total Debt

$535.00K

-46.3%

Accounts Receivable

$1.91M

-17.7%

Inventory

$13.61M

-16.0%

Long Term Debt

$42.00K

-92.1%

Short Term Debt

$493.00K

+6.9%

Return on Assets

-70.56%

N/A

Return on Invested Capital

-1.08%

N/A

Free Cash Flow

-$5.46M

-218.2%

Operating Cash Flow

-$4.74M

-167.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TELATELA Bio, Inc.

TELATELA Bio, Inc.$0.86-6.01%

YI111, Inc.

YI111, Inc.$3.79+2.43%

MDAISpectral AI, Inc.

MDAISpectral AI, Inc.$1.66+1.84%

GNTAGenenta Science S.p.A.

GNTAGenenta Science S.p.A.$1.31-1.50%

CTSOCytosorbents Corporation

CTSOCytosorbents Corporation$0.40+3.61%

RNTXRein Therapeutics Inc.

RNTXRein Therapeutics Inc.$0.79+10.37%

ICCMIceCure Medical Ltd

ICCMIceCure Medical Ltd$3.08-4.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$114.92+0.06%

NVDANvidia

NVDANvidia$218.99-0.00%

TTDThe Trade Desk

TTDThe Trade Desk$17.67-0.07%

SOUNSoundHound AI

SOUNSoundHound AI$7.08+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.68-0.01%

INTCIntel

INTCIntel$99.81-0.01%

PATHUiPath

PATHUiPath$14.00+0.01%

Questions About PETS

What is the current price of PetMed Express?

PetMed Express is trading at $1.97 per share.

What is the 52-week range for PetMed Express?

Over the past 52 weeks, PetMed Express has traded between $1.57 and $4.10.

How much debt does PetMed Express have?

As of the most recent reporting period, PetMed Express reported total debt of $535.00K.

How much cash does PetMed Express have on hand?

PetMed Express reported $21.41M in cash and cash equivalents in its most recent financial results.

What is PetMed Express’s dividend yield?

PetMed Express does not currently have a dividend yield.

PetMed Express(NASDAQ) PETS

PetMed Express Financials at a Glance

PETS News

Why PetMed Express Was a Dog of a Stock This Week

This Under-the-Radar E-Commerce Stock Is Aiming to Expand Its Market

Is PetMed's 4.3% Yield Safe?

Pet Stocks Have Gone to the Dogs This Earnings Season

PetMed Express Earnings: Its Bite Is Worse Than Its Bark

Why PetMed Express Stock Is Sinking Today

Why Petmed Express Stock Skyrocketed Today

What's Behind PetMed Express' Disappointing Q4 Results

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PetMed Express

Products and Services

Growth and Expansion

What Makes PetMed Express Stand Out

Five Things You Need to Know

Bottom Line

PETS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PetMed Express Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PETS

What is the current price of PetMed Express?

What is the 52-week range for PetMed Express?

How much debt does PetMed Express have?

How much cash does PetMed Express have on hand?

What is PetMed Express’s dividend yield?

Premium Investing Services